Apceth GmbH & Co. KG Report issue

For profit Phase 2
Founded: Munich Germany (2007)
Status: Acquired by Hitachi Chemical (2019)

Organization Overview

First Clinical Trial
2011
NCT01351610
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree